| nt | Nucleotide |
| FDA | Food and Drug Administration |
| RNAi | RNA interference |
| CPP | Cell-penetrating Peptide |
| RISC | RNA-Induced Silencing Complex |
| aiRNA | Asymmetric interfering RNA |
| DsiRNA | Dicer-substrate siRNA |
| sisiRNA | Small internally segmented interfering RNA |
| ARC | Antibody siRNA Conjugate |
| IGF1 | Insulin-like Growth Factor 1 |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| PSMA | Prostate-specific Membrane Antigen |
| ASGRP | Asialoglycoprotein receptor |
| GalNAc | N-acetylgalactosamine |
| HDL | High Density Lipoprotein |
| LDL | Low Density Lipoprotein |
| SR-BI | Scavenger Receptor Class B Member 1 |
| CDM | Carboxylated Dimethyl Maleic acid |
| NAG | N-Acetyl-d-Glucosamine |
| LCA | Lithocholic Acid |
| DCA | Docosanoic Acid |
| PC-DCA | Phosphocholine-DCA |
| HBFC | sulfosuccinimidyl 4-(p-maleimidophenyl)butyrate |
| MBS | m-MaleimidoBenzoyl N-hydroxySuccinimide |
| SPDP | Succinimidyl 3-(2-PyridylDithio)Propionate |
| CDK9 | Cyclin-Dependent Kinase 9 |
| MMP2 | Matrix MetalloPeptidase 2 |
| LCST | Lower Critical Solution Temperature |
| SNA | Spherical Nucleic Acid |
| MN | Magnetic Nanoparticle |
| QD | Quantum Dot |